Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's EBIT?
- Aurinia Pharmaceuticals (AUPH) reported EBIT of $46.34M in Q2 2026.
- How has Aurinia Pharmaceuticals's EBIT changed year-over-year?
- Aurinia Pharmaceuticals's EBIT increased by 130.7% year-over-year, from $20.08M to $46.34M.
- What is the long-term trend for Aurinia Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's EBIT has grown at a -12.7% compound annual growth rate (CAGR), from -$180.74M to $104.91M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Aurinia Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude